PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD

2013-11-19
(Press-News.org) Contact information: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences
In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD (SALT LAKE CITY)—Drugs known as PDE3 inhibitors save many lives by helping failing hearts do a better job of pumping blood. But those same medications come with a sometimes deadly cost when taken for long periods: an increased risk for sudden cardiac death.

The drugs work by inhibiting PDE3A, an enzyme that regulates how the heart pumps blood. When PDE3A is inhibited, the heart contracts more forcefully, pumping more blood.

Developing a medication that has the benefits of current drugs but doesn't increase the risk for sudden cardiac death associated has eluded researchers. But an international collaboration led by two Utah researchers is a key first step in finding out whether such a drug may one day be developed.

The research, funded by the Department of Veterans Affairs, was published in the Proceedings of the National Academy of Sciences (PNAS) online the week of Nov. 18, 2013. Matthew A. Movsesian, M.D., professor of medicine at the University of Utah School of Medicine and a cardiologist at the George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, is the senior author. Fabrice Vandeput, Ph.D., a postdoctoral fellow in cardiology at the University of Utah and the VA Medical Center, is first author.

PDE3A comes in three types, or isoforms. PDE3A inhibitors work by inhibiting all three isoforms of the enzyme. Working with colleagues from the United States and Scotland, Vandeput and Movsesian made an important discovery: two of those isoforms, PDE3A1 and PDE3A2, are regulated individually and interact with different proteins in a cell.

"If those isoforms are regulated differently, this tells us they probably are doing different things in cells. And if they interact with different proteins, this means there are molecules that bind to one isoform and not the other," Movsesian says.

That could make it possible to develop a drug that targets one or other of the isoforms to inhibit PDE3A without upping the risk of sudden cardiac death. Years of work must be done before such a drug could be developed and available to heart failure patients. Researchers need to learn much more about the isoforms to understand their roles in how the heart contracts to pump blood (called contractility). They also need to know whether either form of PDE3A contributes to sudden cardiac death in those taking current drugs.

It's also possible that research could determine neither of the isoforms would be a good target for drugs, according to Movsesian, also a professor of pharmacology and toxicology.

"We don't know for certain if these isoforms will ultimately prove to be good targets for drugs," he says. "But we now have reason to believe we could target one or the other."

About 5.7 million people in the United States have heart failure, according to the Centers for Disease Control and Prevention (CDC), with more than 55,000 deaths directly attributed to the condition annually. In 2008, heart failure was a contributing cause in 280,000 deaths, according to the CDC.

PDE3 inhibitors can be taken for shorter periods, when someone has a heart attack and needs help recovering, for example, or for a year or more, such as when a patient with heart failure waits for a transplant or can't survive without the drug. In patients who take them for longer periods, an increase in the mortality rate from sudden cardiac death may outweigh the benefits of increasing cardiac contractility, according to Movsesian.

### END


ELSE PRESS RELEASES FROM THIS DATE:

National study finds renal stenting does not improve outcomes for renal artery stenosis patients

2013-11-19
National study finds renal stenting does not improve outcomes for renal artery stenosis patients Rhode Island Hospital researchers play lead roles in study; will present findings at the annual meeting of the American Heart Association PROVIDENCE, R.I. – According to the findings ...

2 studies on the use of breast MRI

2013-11-19
2 studies on the use of breast MRI CHICAGO – The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine, a JAMA ...

Beta-blockers before surgery appear associated with lower risk of heart-related events

2013-11-19
Beta-blockers before surgery appear associated with lower risk of heart-related events Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) ...

Poorer, rural counties have lower CPR training rates

2013-11-19
Poorer, rural counties have lower CPR training rates Cardiopulmonary resuscitation (CPR) training appears to be lower in more rural counties, those with higher proportions of black and Hispanic residents and lower household incomes, and in the South, Midwest ...

Drinking more milk as a teenager does not lower risk of hip fracture later

2013-11-19
Drinking more milk as a teenager does not lower risk of hip fracture later Drinking more milk as a teenager apparently does not lower the risk of hip fracture as an older adult and instead appears to increase that risk for men, according to a study published by ...

Preterm birth risk increases for pregnant women exposed to phthalates

2013-11-19
Preterm birth risk increases for pregnant women exposed to phthalates The odds of preterm delivery appear to increase for pregnant women exposed to phthalates, chemicals people are exposed to through contaminated food and water and in a variety of products ...

Gene plays major role in suppressing cancer

2013-11-19
Gene plays major role in suppressing cancer Adelaide researchers have found that a specific gene plays an important role in suppressing lymphoma, a type of blood cell cancer. The caspase-2 gene is related to a family of proteins that are essential for ...

Tackling early socioeconomic inequality as important as encouraging smoking cessation

2013-11-19
Tackling early socioeconomic inequality as important as encouraging smoking cessation Although health behaviours such as smoking are directly linked to the majority of early deaths in the UK, tackling these individual factors fails to address the underlying ...

Bacteria recycle broken DNA

2013-11-19
Bacteria recycle broken DNA Bacteria recycle broken DNA that bacteria can take up small as well as large pieces of old DNA from this scrapheap and include it in their own genome. This discovery may have major consequences – both in connection ...

A vexing math problem finds an elegant solution

2013-11-19
A vexing math problem finds an elegant solution ITHACA, N.Y. – A famous math problem that has vexed mathematicians for decades has met an elegant solution by Cornell University researchers. Graduate student Yash Lodha, working with Justin Moore, professor of mathematics, ...

LAST 30 PRESS RELEASES:

Osteoporosis treatment benefits people older than 80

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

Thyroid treatment may improve gut health in people with hypothyroidism

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

High blood sugar may have a negative impact on men’s sexual health

Emotional health of parents tied to well-being of children with growth hormone deficiency

Oxytocin may reduce mood changes in women with disrupted sleep

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

[Press-News.org] In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD